Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 6 minute read General business news Is Japan’s chip revival strategy finally paying off? A closer look at subsidies, talent, and national resilience Is Japan’s chip comeback real? Explore how subsidies, fabs, and global partnerships are reshaping its semiconductor industry for the AI age. byVenkateshDecember 2, 2025